Physician profile
Jason Morvant
NPI 1184696502
$13,717.27
in general payments reported to CMS, 2019-2025
22 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,808 · 2020: $924 · 2021: $988 · 2022: $3,430 · 2023: $1,165 · 2024: $4,928 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,696 · Travel and Lodging: $1,863 · Education: $1,000 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,696.10 |
| Travel and Lodging | $1,863.10 |
| Education | $1,000.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,113.32 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $1,568.10 | 2023-2025 | |
| Stryker Corporation | $1,533.13 | 2019-2024 | Mako |
| Ethicon US, LLC | $1,248.14 | 2019-2025 | Ethicon, Vistaseal, Megadyne |
| Allergan, INC. | $908.56 | 2020-2022 | |
| Biom'Up France Sas | $822.25 | 2020-2021 | |
| Dilon Technologies, INC. | $326.14 | 2023-2024 | Hemoblast Bellows |
| Covidien LP | $248.35 | 2019-2020 | |
| Medical Device Business Services, INC. | $228.32 | 2022 | |
| Organogenesis INC. | $202.58 | 2024 | |
| Biom'Up Sa | $96.11 | 2019 | |
| Davol INC. | $91.73 | 2023 | Arista Ah Flexitip |
| Kerecis Limited | $62.35 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Conmed Corporation | $55.56 | 2023 | Airseal |
| Lilly USA, LLC | $42.32 | 2024 | Zepbound |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $39.10 | 2020-2021 | |
| Medtronic, INC. | $34.57 | 2021-2024 | Venaseal |
| Heron Therapeutics, INC. | $24.28 | 2023 | Zynrelef |
| Convatec INC. | $23.36 | 2023 | |
| Becton, Dickinson and Company | $20.17 | 2023 | Phasix Mesh |
| Sanara Medtech INC. | $16.13 | 2025 | Celleraterx |
| Innocoll Pharmaceuticals Limited | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Morvant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.